| Variable | Pancreatic cancer n = 153 (%) | Ampullary cancer n = 34 (%) |
| Sex | ||
| Male | 83 (54) | 19 (56) |
| Female | 70 (46) | 15 (44) |
| Age (years) | ||
| Mean | 66 | 64 |
| Median | 67 | 66 |
| Range | 37–86 | 41–91 |
| Stage (UICC) | ||
| I | 24 (15) | 14 (41) |
| II | 60 (39) | 16 (47) |
| III | 24 (16) | 1 (3) |
| IV | 27 (18) | 3 (9) |
| Unknown | 18 (12) | |
| Median overall survival | ||
| Months | 7 | 19 |
| Range | 1–134 | 3–119 |
| Median overall survival by | ||
| Curative resection | 10 | 28 |
| Palliative surgery | 6 | 5 |
| Inoperable | 4 | 5 |
| Primary surgical treatment | ||
| Curative resection | 62 (40) | 27 (79) |
| Palliative surgery | 62 (40) | 6 (18) |
| Inoperable | 29 (20) | 1 (3) |
| Ep-CAM overexpression | ||
| Yes | 85 (56) | 29 (85) |
| No | 68 (44) | 5 (15) |
UICC, International Union Against Cancer.